Get the Stockscreener App
0.3458
6.66%
0.0216
Pre-market:
.36
0.0142
+4.11%
Co Diagnostics Inc stock is traded at $0.3458, with a volume of 740.73K.
It is up +6.66% in the last 24 hours and down -21.03% over the past month.
Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV.The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.
See More
Previous Close:
$0.3242
Open:
$0.33
24h Volume:
740.73K
Relative Volume:
0.12
Market Cap:
$13.32M
Revenue:
$7.11M
Net Income/Loss:
$-41.28M
P/E Ratio:
-0.2506
EPS:
-1.38
Net Cash Flow:
$-26.84M
1W Performance:
-10.11%
1M Performance:
-21.03%
6M Performance:
-0.46%
1Y Performance:
-72.98%
1-Day Range:
$0.33
$0.36
1-Week Range:
$0.31
$0.4199
52-Week Range:
$0.2275
$1.29
Co Diagnostics Inc Stock (CODX) Company Profile
Name
Co Diagnostics Inc
Sector
Industry
Phone
(801) 278-9769
Address
4049 SOUTH HIGHLAND DRIVE, SALT LAKE CITY
Compare CODX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CODX
Co Diagnostics Inc
|
0.3458 | 15.61M | 7.11M | -41.28M | -26.84M | -1.38 |
|
ABT
Abbott Laboratories
|
129.51 | 223.72B | 43.84B | 13.94B | 6.78B | 7.9979 |
|
BSX
Boston Scientific Corp
|
100.53 | 147.05B | 18.49B | 2.50B | 3.49B | 1.6801 |
|
SYK
Stryker Corp
|
381.22 | 143.14B | 23.82B | 2.92B | 4.02B | 7.5574 |
|
MDT
Medtronic Plc
|
95.92 | 122.86B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
75.29 | 43.82B | 5.69B | 1.41B | 577.90M | 6.9828 |
Co Diagnostics Inc Stock (CODX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-12-22 | Downgrade | Sidoti | Buy → Neutral |
| Dec-29-21 | Initiated | Sidoti | Buy |
| Mar-29-21 | Downgrade | Maxim Group | Buy → Hold |
| May-20-20 | Upgrade | Maxim Group | Hold → Buy |
| May-18-20 | Reiterated | H.C. Wainwright | Buy |
| Mar-09-20 | Reiterated | H.C. Wainwright | Buy |
| Mar-03-20 | Downgrade | Maxim Group | Buy → Hold |
View All
Co Diagnostics Inc Stock (CODX) Latest News
How sentiment analysis helps forecast Co Diagnostics Inc.Weekly Loss Report & Free Growth Oriented Trading Recommendations - newser.com
Co Diagnostics Inc. recovery potential after sell off2025 Geopolitical Influence & Long Hold Capital Preservation Tips - newser.com
What’s next for Co Diagnostics Inc. stock price2025 Market Outlook & Momentum Based Trading Signals - newser.com
Analyzing drawdowns of Co Diagnostics Inc. with statistical toolsRate Cut & AI Enhanced Trading Signals - newser.com
Co Diagnostics Inc. stock retracement – recovery analysisNew Guidance & Low Risk Growth Stock Ideas - newser.com
Co-Diagnostics Launches New Equity Distribution Agreement - MSN
Why Co Diagnostics Inc. stock could rally in 2025Portfolio Return Report & Real-Time Buy Zone Alerts - newser.com
Is Co Diagnostics Inc. building a consolidation base2025 Breakouts & Breakdowns & Reliable Momentum Entry Alerts - newser.com
Co-Diagnostics enters equity distribution agreement with Maxim Group - MarketScreener
Will Co Diagnostics Inc. stock benefit from AI adoptionTrade Volume Report & AI Driven Stock Reports - newser.com
Is Co Diagnostics Inc. still worth holding after the dip2025 Winners & Losers & High Win Rate Trade Tips - newser.com
Using Ichimoku Cloud for Co Diagnostics Inc. technicalsPortfolio Performance Report & Entry Point Confirmation Signals - newser.com
Tools to assess Co Diagnostics Inc.’s risk profileMarket Performance Recap & Reliable Price Breakout Alerts - newser.com
What analysts say about Co Diagnostics Inc stockEarnings Season Recap & Access Our Free Weekly Investment Letter - earlytimes.in
Why Co Diagnostics Inc. stock is popular among millennialsWatch List & Real-Time Sentiment Analysis - nchmf.gov.vn
Is Co Diagnostics Inc. stock positioned well for digital economyWeekly Earnings Recap & Safe Entry Zone Tips - nchmf.gov.vn
How risky is Co Diagnostics Inc. stock now2025 Fundamental Recap & AI Enhanced Trading Signals - nchmf.gov.vn
Why Co Diagnostics Inc. stock is a must watch in 20252025 Volume Leaders & Daily Technical Stock Forecast Reports - nchmf.gov.vn
Can volume confirm reversal in Co Diagnostics Inc.Share Buyback & Free Expert Approved Momentum Trade Ideas - newser.com
Co-Diagnostics Announces Development of Proprietary Sample Prep Instrument for PoC Testing - The Malaysian Reserve
Published on: 2025-10-16 22:23:21 - newser.com
D. Boral Capital Maintains Co-Diagnostics (CODX) Buy Recommendation - Nasdaq
CODX Analyst Ratings Update: Target Price Maintained at $3.00 | - GuruFocus
Co-Diagnostics (CODX) Unveils New Sample Preparation Instrument for TB Testing - GuruFocus
Co Diagnostics Inc Stock Analysis and ForecastRetail Trading Trends & Hidden Gems with Outstanding Profit Margins - earlytimes.in
Working capital per share of Co-Diagnostics, Inc. – SWB:C97 - TradingView
Co-Diagnostics prices 9.62M shares at 40c in registered direct offering - MSN
How Co Diagnostics Inc. stock compares to industry benchmarksQuarterly Performance Summary & Technical Buy Zone Confirmation - newser.com
What the charts say about Co Diagnostics Inc. todayJuly 2025 Price Swings & Capital Efficiency Focused Strategies - newser.com
Co Diagnostics Inc Stock (CODX) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.59%
0.18%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):